Our finding that TGFβ-reduction of SnoN protein level in breast cancer cells may not be affected by the sumoylation status of SnoN raises the key question whether TGFβ signaling may act via other mechanisms to differentially regulate the abundance of sumoylated forms of SnoN in cells. This evidence concerns the gene SKIL and breast carcinoma.